BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2332732)

  • 21. Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells.
    Konttinen YT; Bluestein HG; Zvaifler NJ
    J Immunol; 1985 Apr; 134(4):2287-93. PubMed ID: 2857749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-stimulating growth factor production by B-cell lines derived from Burkitt's lymphomas and other lines transformed in vitro by Epstein-Barr virus.
    Blazar BA; Sutton LM; Strome M
    Cancer Res; 1983 Oct; 43(10):4562-8. PubMed ID: 6309371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation.
    Romagnani S; Giudizi GM; Almerigogna F; Biagiotti R; Alessi A; Mingari C; Liang CM; Moretta L; Ricci M
    Eur J Immunol; 1986 Jun; 16(6):623-9. PubMed ID: 3087756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth control or terminal differentiation: endogenous production and differential activities of vitamin A metabolites in HL-60 cells.
    Eppinger TM; Buck J; Hämmerling U
    J Exp Med; 1993 Dec; 178(6):1995-2005. PubMed ID: 8245778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding of retinoids to human breast cancer cell lines and their effects on cell growth.
    Lacroix A; Lippman ME
    J Clin Invest; 1980 Mar; 65(3):586-91. PubMed ID: 7188772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complement-dependent B-cell activation by cobra venom factor and other mitogens?
    Dukor P; Schumann G; Gisler RH; Dierich M; König W; Hadding U; Bitter-Suermann D
    J Exp Med; 1974 Feb; 139(2):337-54. PubMed ID: 4589989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. All trans-retinol effects on human colon adenocarcinoma cultured cells: biological and nmr studies.
    Rosi A; Guidoni L; Mariutti G; Viti V
    Physiol Chem Phys Med NMR; 1987; 19(4):235-40. PubMed ID: 3449863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of epidermal growth factor-like growth factor secretion in tracheobronchial epithelial cells by vitamin A.
    Miller LA; Cheng LZ; Wu R
    Cancer Res; 1993 Jun; 53(11):2527-33. PubMed ID: 8495415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Culture and stimulation of human T- and B-lymphocytes.
    Weichert H; Lehmann J; Ambrosius H
    Biomed Biochim Acta; 1990; 49(10):999-1004. PubMed ID: 2080910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinol and beta-carotene concentrations in skin, papillomas and carcinomas, liver, and serum of mice fed retinoic acid or beta-carotene to suppress skin tumor formation.
    Jones CS; Sly L; Chen LC; Ben T; Brugh-Collins M; Lichti U; De Luca LM
    Nutr Cancer; 1994; 21(1):83-93. PubMed ID: 7910392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of epithelial markers and retinoid-binding proteins in retinol- or retinoic acid-treated intestinal cells in vitro.
    Plateroti M; Sambuy Y; Nobili F; Bises G; Perozzi G
    Exp Cell Res; 1993 Sep; 208(1):137-47. PubMed ID: 8395395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination of mutant EL-4 thymoma cells and EBV-infection in B lymphocyte activation a) EBV-infection of EL-4-activated lymphocytes. b) Use of EL-4 cells as feeders for lymphoblastoid cell lines.
    Barcellini W; Borghi MO; Nicoletti F; Bonara P; Fain C; Meroni PL
    J Clin Lab Immunol; 1990 Sep; 33(1):21-8. PubMed ID: 1966941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of difference between retinoic acid and retinol in stimulating progesterone production by luteinizing granulosa cells in vitro.
    Bagavandoss P; Midgley AR
    Endocrinology; 1987 Jul; 121(1):420-8. PubMed ID: 3036474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The roles of interleukin 2 and interferon-gamma in human B cell activation, growth and differentiation.
    Jelinek DF; Splawski JB; Lipsky PE
    Eur J Immunol; 1986 Aug; 16(8):925-32. PubMed ID: 3091378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2.
    Tseng CT; Springgate CF; Piela TH; Choi YS
    J Immunol; 1987 Apr; 138(8):2554-60. PubMed ID: 3031160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B cell growth-promoting activity of recombinant human interleukin 4.
    Defrance T; Vanbervliet B; Aubry JP; Takebe Y; Arai N; Miyajima A; Yokota T; Lee F; Arai K; de Vries JE
    J Immunol; 1987 Aug; 139(4):1135-41. PubMed ID: 3112225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth modification of normal and tumor cell lines with retinol.
    Audette M; Page M
    Cancer Detect Prev; 1983; 6(6):497-505. PubMed ID: 6661740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
    Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
    J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel signaling by vitamin A/retinol promotes self renewal of mouse embryonic stem cells by activating PI3K/Akt signaling pathway via insulin-like growth factor-1 receptor.
    Chen L; Khillan JS
    Stem Cells; 2010 Jan; 28(1):57-63. PubMed ID: 19890980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different maturation capabilities of chronic lymphocytic leukaemia lymphocytes in vitro.
    Rozynkowa D; Rupniewska ZM; Antosz H
    Cytobios; 1986; 48(192):31-7. PubMed ID: 3491741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.